Document is current
Any future updates will be listed below
-
Authors
Hong, Shicui
Yu, Miao
Zheng, Yifeng
Wang, Shengqi
Zhang, Juping
Pan, Bo
Situ, Honglin
Guo, Li
Zhong, Shaowen
Chen, Ying
Li, Yunxi
Yang, Lingling
Li, Yan
Wang, Zhiyu
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2200065009 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Clinical efficacy and multi-omics analysis of Si–Ni–San for depression treatment in breast cancer patients: a randomized, double-blind, placebo-controlled, crossover trial
https://doi.org/10.1186/s13020-025-01283-y
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82374446)
National Natural Science Foundation of China (82104869)
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 17 November 2025
First Online: 6 January 2026
Declarations
:
: All participants provided written informed consent and the protocol was approved by the Medical Ethics Committee of Guangdong Provincial hospital of Chinese medicine (2022-177-01).
: We declare that the Publisher has the Author’s permission to publish the relevant Contribution.
: The author(s) declared no potential conflicts of interest.
